Delta Accumulation, LLC Amgen Inc Put Options Transaction History

Delta Accumulation, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $4.28 Million - $5.16 Million	15,900 Added 60.46%	42,200 $12 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $485,830 - $548,074	-1,900 Reduced 6.74%	26,300 $7.57 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $1.86 Million - $2.31 Million	8,500 Added 43.15%	28,200 $7.58 Million
Q2 2023 Aug 10, 2023	BUY	$214.27 - $253.37 $2.36 Million - $2.79 Million	11,000 Added 126.44%	19,700 $4.37 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $1.4 Million - $1.71 Million	6,200 Added 248.0%	8,700 $2.1 Million

Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $572,575 - $727,525	2,500 New	2,500 $656,000
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $1.87 Million - $2.08 Million	-8,100 Reduced 61.83%	5,000 $1.22 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $1.75 Million - $1.94 Million	8,000 Added 156.86%	13,100 $3.17 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $1.01 Million - $1.16 Million	5,100 New	5,100 $1.15 Million

2,936

401M

6.59M

6.6M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Delta Accumulation, LLC, based on Form 13F filings with the SEC.

Stay updated on Delta Accumulation, LLC with notifications on news.